Shareholder Analysis

Substantial Shareholdings

As at 8 November 2018, the Company’s issued share capital consists of 213,478,084 ordinary shares with a nominal value of 5p each (“Ordinary Shares”), each share having equal voting rights.

As at 8 November 2018 the Company’s major shareholders are:

Table: “Substantial shareholdings”

ShareholdersPercentage of shares held
Octopus Investments Limited10.20%
AXA SA8.10%
Blackrock Inc7.50%
Canaccord Genuity Group Inc6.55%
Investec Group4.83%
Groupama4.43%
Aviva plc4.15%
Charles Stanley Group3.73%
Schroders3.20%

 

In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 8 November 2018, the percentage of the Company’s issued share capital that is not in public hands is 2.36%. This percentage consists of the holdings of the directors’ beneficial holdings and the holdings of the AMS Trustee Company in respect of the Company’s Deferred Share Bonus Scheme. The Company’s free float is 97.64%.

Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com.